Riccardo Scarin

Riccardo Scarin is an experienced professional in the field of pharmaceutical biotechnology, currently working at Atlas Molecular Pharma as an ESR in the Marie Curie GLYTUNES ITN project, focusing on targeted therapies for rare diseases, particularly Tyrosinemia Type 1. Past roles include guest scientist positions at the Max Planck Institute of Colloids and Interfaces and GlycoUniverse GmbH & Co. KGaA, as well as conducting a master's thesis at Universität Wien. Riccardo also gained practical experience during an internship at Fondazione Edmund Mach, where skills in HPLC, mass spectrometry analysis, and molecular biology techniques were developed. Educationally, Riccardo holds a master's degree in pharmaceutical biotechnology and a bachelor's degree in pharmaceutical sciences, both from Università degli Studi di Padova.